BRCA2 and neoplasm: Large population-based studies have also established an increased risk for BRCA2 carriers of early-onset disease, higher tumor grade and metastatic presentation, whereas other DDR genes exhibit more heterogeneous and gene-specific penetrance [13,14,15].